Hyperliquid Strategies Launches $30 Million HYPE Token Buyback
Hyperliquid Strategies has announced a $30 million stock repurchase program for its HYPE token treasury, signaling a strategic push to enhance shareholder value and institutional participation. The digital asset treasury, formed through a merger of Sonnet BioTherapeutics and the SPAC Rorschach, will execute the buyback over the next 12 months. Hyperliquid’s CEO David Schamis emphasized […]